Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Durgadevi Veeraiyan
Observed names:
Durga Devi Veeraiyan,
DurgaDevi Veeraiyan
Institutions:
Sri Shankara Cancer Hospital and Research Center,
Sri Shankara National Centre for Cancer Prevention and Research
Observed institutions:
Sri Shankara Cancer Hospital and Research Center,
Sri Shankara National Centre for Cancer Prevention and Research
OpenAlex ID:
A5113250492
NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the Iceberg
2024
·
Sri Vidya Ramisetti
, Tapas Patra
, et al.
·
Archivos de Bronconeumología
·
23
A comparative analysis indicates SLC7A11 expression regulate the prognostic value of KEAP1-NFE2L2-CUL3 mutations in human uterine corpus endometrial carcinoma
2024
·
Akhileshwar Namani
, Durgadevi Veeraiyan
, et al.
·
Free Radical Biology and Medicine
·
6
Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancer
2025
·
Srivatsa N
, Hari PS
, et al.
·
BMC Cancer
·
5
PDF
Immune infiltration in TP53 missense mutant contributes to poor prognosis in hepatocellular carcinoma, unlike CTNNB1 mutations
2025
·
Durgadevi Veeraiyan
, Vishnu Kurpad
, et al.
·
Malignancy Spectrum
·
4
PDF
Temoporfin loaded g-C3N4/CuO nanocarrier for treatment of hypoxic tumors by synergistic chemo-photodynamic therapy
2025
·
Saumya
, Durgadevi Veeraiyan
, et al.
·
Diamond and Related Materials
·
2
Genomic Amplification of CCNE1 Is Associated with an Immunosuppressive Tumor Microenvironment and Adverse Clinical Outcome in High-Grade Serous Ovarian Cancer
2026
·
Annapurna Vadaparty
, Durgadevi Veeraiyan
, et al.
·
OMICS A Journal of Integrative Biology
Tumor-associated macrophage (TAM) score as an independent predictor of recurrence in residual disease after neoadjuvant chemotherapy and for identification of high-risk patients for adjuvant escalation.
2026
·
Aruna Korlimarla
, Hari P S
, et al.
·
Journal of Clinical Oncology
Sex-based molecular and prognostic disparities in pan-cancer: an analysis across the global cohorts
2025
·
Guruguhan Sivakumar
, Tapas Patra
, et al.
·
Clinical & Translational Oncology
Abstract P1-06-23: Extracellular matrix in Young Onset Breast Cancer – A dynamic niche as a therapeutic target
2025
·
Lohita Krishna Kanyadhara
, Srinath B S
, et al.
·
Clinical Cancer Research
MicroRNA-mediated resistance mechanisms in NAT-treated HER2-positive breast cancer (BC): A single centre retrospective analysis from matched primary and residual tumours.
2025
·
Sandhya Appachu Mathranda
, Praveen Kumar
, et al.
·
Journal of Clinical Oncology
PDF
Contrasting prognostic role of KEAP1-NFE2L2-CUL3 mutation in human Uterine Corpus Endometrial Carcinoma (UCEC)
2024
·
Akhileswar Namani
, Durga Devi Veeraiyan
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
11
Citation count:
40
H-index:
4
I10-index:
1
Year
Topic
Type